Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study
ConclusionsDM/Q was well tolerated, and it significantly reduced PBA episodes in study participants with TBI. Changes in CNS-LS and PBA episode count were similar to changes with DM/Q in phase 3 trials.Level of EvidenceII
Source: PMandR - Category: Rehabilitation Source Type: research
More News: ALS | Brain | Dementia | Men | Multiple Sclerosis | Neurology | Psychiatry | Stroke | Study